Browse our collection
This pragmatic, multicenter trial the Diuretic Comparison Project, compared chlorthalidone and hydrochlorothiazide in preventing major …
This phase 3, double-blind randomized trial (STEP 1) evaluated once-weekly subcutaneous semaglutide (2.4 mg) versus …
This postmortem study investigated sudden cardiac death and myocardial fibrosis in HIV-positive individuals using forensic …
This perspective article describes efforts to increase diversity in the University of Utah Family Medicine …
This editorial discusses the role of aldosterone in treatment resistant hypertension (defined as blood pressure …
Congenital hyperinsulinism, often caused by mutations in ABCC8 or KCNJ11, leads to severe hypoglycemia and may require pancreatectomy. …
This multicenter, double-blind randomized trial (SCORED) evaluated the efficacy of sotagliflozin, a dual SGLT1/SGLT2 inhibitor …
This editorial discusses the GALACTIC-HF trial results evaluating omecamtiv mecarbil, a cardiac myosin activator that …
This correspondence reports the rapid cardiovascular effects of belzutifan, a hypoxia inducible factor 2α (HIF …
This editorial examines the STEP 1 trial evaluating once-weekly subcutaneous semaglutide in adults with overweight …
This patient-facing multimedia article explains atrial fibrillation (AF) the most common sustained cardiac arrhythmia its …
This review article examines the health effects of endocrine disrupting chemicals (EDCs) derived from fossil …
This cross-sectional analysis evaluated U.S. adults with diagnosed diabetes participating in NHANES (1999–2018) to assess …
This phase 2, double blind, randomized, placebo controlled trial evaluated the effect of lixisenatide, a …
This editorial examines the rapid expansion and reimbursement of remote patient monitoring (RPM) services, accelerated …
This preliminary report describes the outbreak of Zika virus disease (ZVD) in Colombia beginning in …
This randomized, placebo-controlled trial (TIPS-3) investigated whether a fixed-dose polypill comprising simvastatin, atenolol, hydrochlorothiazide, and …
This phase 2 trial evaluated the efficacy of ponsegromab, a humanized monoclonal antibody targeting growth …
This editorial reflects on the ADAPTABLE trial, which evaluated 81 mg versus 325 mg daily …
This correspondence presents 10 year outcomes from the Teen-LABS study, a prospective multicenter observational cohort …
This multicenter randomized controlled trial (REHAB-HF) assessed the impact of a transitional, tailored, progressive physical …
This multinational cohort study from the PURE trial examines the relationship between dietary glycemic index …
This image-based case report describes a 58-year-old man who experienced intermittent dizziness and palpitations exclusively …
This image-based case report describes a 67-year-old woman who presented with fatigue and anorexia …
This study evaluated the efficacy and safety of once weekly semaglutide (2.4 mg) in patients …
This editorial analyzes findings from the FLOWER-MI trial comparing fractional flow reserve (FFR)-guided versus angiography-guided …
This perspective article marks the 50th anniversary of the National Academy of Medicine and traces …
